TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF GLOBAL CELL BASED ASSAYS MARKET 28
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GLOBAL CELL BASED ASSAYS MARKET: GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 DBMR TRIPOD DATA VALIDATION MODEL 36
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.7 DBMR MARKET POSITION GRID (ON THE BASIS OF PRODUCTS) 40
2.8 DBMR MARKET POSITION GRID 41
2.9 DBMR VENDOR SHARE ANALYSIS 42
2.10 MULTIVARIATE MODELING 43
2.11 PRODUCTS LIFELINE CURVE 44
2.12 SECONDARY SOURCES 45
2.13 ASSUMPTIONS 45
3 MARKET OVERVIEW 46
3.1 DRIVERS 48
3.1.1 INCREASING INCIDENCE OF CHRONIC DISEASES 48
3.1.2 RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES 50
3.1.3 INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURE 51
3.2 RESTRAINT 53
3.2.1 STRINGENT REGULATORY REQUIREMENTS 53
3.2.2 HIGH COST OF INSTRUMENTATION 53
3.3 OPPORTUNITIES 54
3.3.1 TECHNOLOGICAL ADVANCEMENTS 54
3.3.2 STRATEGIC INITIATIVE BY THE MARKET PLAYERS 54
3.4 CHALLENGES 55
3.4.1 CHALLENGING ANALYSIS PROCEDURE 55
4 EXECUTIVE SUMMARY 56
5 PREMIUM INSIGHTS 58
6 GLOBAL CELL-BASED ASSAYS MARKET, BY TYPE 60
6.1 OVERVIEW 61
6.2 CELL VIABILITY ASSAY 63
6.3 CYTOTOXICITY ASSAY 64
6.4 CELL PROLIFERATION ASSAY 64
6.5 CELL DEATH ASSAY 65
6.6 OTHERS 65
7 GLOBAL CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICES 66
7.1 OVERVIEW 67
7.2 CONSUMABLES 69
7.2.1 ASSAY KITS 70
7.2.2 CELL LINES 70
7.2.2.1 Primary Cell Lines 70
7.2.2.2 Stem Cell Lines 70
7.2.2.3 Immortalized Cell Lines 70
7.2.3 REAGENTS 70
7.2.4 MICROPLATES 70
7.3 SERVICES 71
7.4 INSTRUMENTS AND SOFTWARE 71
8 GLOBAL CELL-BASED ASSAYS MARKET, BY TECHNOLOGY 72
8.1 OVERVIEW 73
8.2 HIGH THROUGHPUT SCREENING 75
8.3 FLOW CYTOMETRY 75
8.4 HIGH CONTENT SCREENING 76
8.5 LABEL FREE DETECTION 76
9 GLOBAL CELL-BASED ASSAYS MARKET, BY APPLICATION 77
9.1 OVERVIEW 78
9.2 DRUG DISCOVERY 80
9.2.1 PREDICTIVE TOXICOLOGY 80
9.2.2 PHARMACODYNAMIC STUDIES 81
9.2.3 ADME RESEARCH 81
9.3 BASIC RESEARCH 81
9.4 OTHERS 81
?
10 GLOBAL CELL-BASED ASSAYS MARKET, BY END USER 82
10.1 OVERVIEW 83
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 85
10.3 CONTRACT RESEARCH ORGANIZATIONS 86
10.4 ACADEMIC & RESEARCH INSTITUTIONS 86
10.5 GOVERNMENT ORGANIZATIONS 87
10.6 OTHERS 87
11 GLOBAL CELL-BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL 88
11.1 OVERVIEW 89
11.2 DIRECT 91
11.3 INDIRECT 91
12 GLOBAL CELL BASED ASSAY MARKET, BY GEOGRAPHY 92
12.1 OVERVIEW 93
12.2 NORTH AMERICA 98
12.2.1 U.S. 104
12.2.2 CANADA 107
12.2.3 MEXICO 110
12.3 EUROPE 113
12.3.1 GERMANY 119
12.3.2 FRANCE 122
12.3.3 UNITED KINGDOM 125
12.3.4 ITALY 128
12.3.5 SPAIN 131
12.3.6 RUSSIA 134
12.3.7 NETHERLANDS 137
12.3.8 SWITZERLAND 140
12.3.9 BEGIUM 143
12.3.10 TURKEY 146
12.3.11 REST OF EUROPE 149
12.4 ASIA-PACIFIC 150
12.4.1 CHINA 156
12.4.2 JAPAN 159
12.4.3 SOUTH KOREA 162
12.4.4 INDIA 165
12.4.5 SINGAPORE 168
12.4.6 AUSTRALIA 171
12.4.7 THAILAND 174
12.4.8 MALAYSIA 177
12.4.9 INDONESIA 180
12.4.10 PHILIPPINES 183
12.4.11 REST OF ASIA-PACIFIC 186
12.5 SOUTH AMERICA 187
12.5.1 BRAZIL 193
12.5.2 REST OF SOUTH AMERICA 196
12.6 MIDDLE EAST AND AFRICA 197
12.6.1 SOUTH AFRICA 203
12.6.2 REST OF MIDDLE EAST AND AFRICA 206
13 GLOBAL CELL BASED ASSAYS MARKET FOR PRODUCTS, COMPANY LANDSCAPE 207
13.1 COMPANY SHARE ANALYSIS: GLOBAL 207
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 208
13.3 COMPANY SHARE ANALYSIS: EUROPE 209
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 210
14 GLOBAL CELL BASED ASSAYS MARKET FOR SERVICES, COMPANY LANDSCAPE 211
14.1 COMPANY SHARE ANALYSIS: GLOBAL 211
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 212
14.3 COMPANY SHARE ANALYSIS: EUROPE 213
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 214
15 COMPANY PROFILE 215
15.1 GENERAL ELECTRIC 215
15.1.1 COMPANY SNAPSHOT 215
15.1.2 REVENUE ANALYSIS 215
15.1.3 COMPANY SHARE ANALYSIS 216
15.1.4 PRODUCT PORTFOLIO 216
15.1.5 RECENT DEVELOPMENTS 217
15.2 DANAHER 218
15.2.1 COMPANY SNAPSHOT 218
15.2.2 REVENUE ANALYSIS 218
15.2.3 COMPANY SHARE ANALYSIS 219
15.2.4 PRODUCT PORTFOLIO 219
15.2.5 RECENT DEVELOPMENT 222
15.3 AGILENT TECHNOLOGIES, INC. 223
15.3.1 19.1 COMPANY SNAPSHOT 223
15.3.2 REVENUE ANALYSIS 223
15.3.3 COMPANY SHARE ANALYSIS 224
15.3.4 PRODUCT PORTFOLIO 224
15.3.5 RECENT DEVELOPMENTS 226
15.4 THERMO FISHER SCIENTIFIC INC 227
15.4.1 COMPANY SNAPSHOT 227
15.4.2 REVENUE ANALYSIS 227
15.4.3 COMPANY SHARE ANALYSIS 228
15.4.4 PRODUCT PORTFOLIO 228
15.4.5 RECENT DEVELOPMENT 254
15.5 MERCK KGAA 255
15.5.1 COMPANY SNAPSHOT 255
15.5.2 REVENUE ANALYSIS 255
15.5.3 PRODUCT PORTFOLIO 256
15.5.4 RECENT DEVELOPMENT 261
15.6 PERKINELMER INC, INC. 262
15.6.1 COMPANY SNAPSHOT 262
15.6.2 REVENUE ANALYSIS 262
15.6.3 PRODUCT PORTFOLIO 263
15.6.4 RECENT DEVELOPMENT 268
15.7 BIO-RAD LABORATORIES, INC. 269
15.7.1 COMPANY SNAPSHOT 269
15.7.2 REVENUE ANALYSIS 269
15.7.3 PRODUCT PORTFOLIO 270
15.7.4 RECENT DEVELOPMENTS 272
15.8 ATCC 273
15.8.1 COMPANY SNAPSHOT 273
15.8.2 PRODUCT PORTFOLIO 273
15.8.3 RECENT DEVELOPMENT 274
15.9 AURELIA BIOSCIENCE LTD. 275
15.9.1 COMPANY SNAPSHOT 275
15.9.2 SERVICE PORTFOLIO 275
15.9.3 RECENT DEVELOPMENT 275
15.10 BD 276
15.10.1 COMPANY SNAPSHOT 276
15.10.2 REVENUE ANALYSIS 276
15.10.3 PRODUCT PORTFOLIO 277
15.10.4 RECENT DEVELOPMENTS 279
15.11 BIOAGILYTIX LABS 280
15.11.1 COMPANY SNAPSHOT 280
15.11.2 SERVICE PORTFOLIO 280
15.11.3 RECENT DEVELOPMENTS 280
?
15.12 BIOVISION INC. 281
15.12.1 COMPANY SNAPSHOT 281
15.12.2 PRODUCT PORTFOLIO 281
15.12.3 RECENT DEVELOPMENT 289
15.13 CELL SIGNALING TECHNOLOGY, INC. 290
15.13.1 COMPANY SNAPSHOT 290
15.13.2 PRODUCT PORTFOLIO 290
15.13.3 RECENT DEVELOPMENT 295
15.14 CISBIO 296
15.14.1 COMPANY SNAPSHOT 296
15.14.2 PRODUCT PORTFOLIO 296
15.14.3 RECENT DEVELOPMENT 304
15.15 ENZO BIOCHEM INC. 305
15.15.1 COMPANY SNAPSHOT 305
15.15.2 REVENUE ANALYSIS 305
15.15.3 PRODUCT PORTFOLIO 306
15.15.4 RECENT DEVELOPMENT 307
15.16 EUROFINS SCIENTIFIC 308
15.16.1 COMPANY SNAPSHOT 308
15.16.2 REVENUE ANALYSIS 308
15.16.3 PRODUCT AND SERVICE PORTFOLIO 309
15.16.4 RECENT DEVELOPMENTS 310
15.17 LAKEPHARMA, INC. 311
15.17.1 COMPANY SNAPSHOT 311
15.17.2 SERVICE PORTFOLIO 311
15.17.3 RECENT DEVELOPMENT 311
15.18 LONZA 312
15.18.1 COMPANY SNAPSHOT 312
15.18.2 REVENUE ANALYSIS 312
15.18.3 SERVICE PORTFOLIO 313
15.18.4 RECENT DEVELOPMENT 315
15.19 MILTENYI BIOTEC 316
15.19.1 COMPANY SNAPSHOT 316
15.19.2 15.2 PRODUCT PORTFOLIO 316
15.19.3 RECENT DEVELOPMENT 317
15.20 XENO DIAGNOSTICS, LLC. 318
15.20.1 COMPANY SNAPSHOT 318
15.20.2 PRODUCT PORTFOLIO 318
15.20.3 RECENT DEVELOPMENT 319
16 QUESTIONNAIRE 320
17 RELATED REPORTS 324